ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,504Medicare Part D Prescriptions Filled, Including Refills

Rank: 279 out of 2094

$684K Total Retail Price of All Prescriptions

Rank: 264 out of 2094

699 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 8,312 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 498 493 1 2
ATORVASTATIN CALCIUM 389 385 2 5
SYNTHROID 375 370 3 44
LOSARTAN POTASSIUM 371 368 4 17
SIMVASTATIN 344 335 5 1
LIPITOR 304 303 6 39
HYDROCHLOROTHIAZIDE 280 272 7 12
CRESTOR 264 233 8 15
ZOLPIDEM TARTRATE 251 251 9 14
LEVOTHYROXINE SODIUM 242 231 10 3
OMEPRAZOLE 170 169 11 4
ZETIA 160 157 12 79
POTASSIUM CHLORIDE 132 130 13 24
NEXIUM 131 130 14 16
METOPROLOL SUCCINATE 117 117 15 9
LOSARTAN-HYDROCHLOROTHIAZIDE 115 115 16 52
FUROSEMIDE 106 106 17 6
PANTOPRAZOLE SODIUM 102 93 18 37
SERTRALINE HCL 99 99 19 26
AZITHROMYCIN 98 96 20 27
PRAVASTATIN SODIUM 92 92 21 18
ATENOLOL 83 80 22 21
DIOVAN 82 82 23 13
ALLOPURINOL 77 77 24 50
ALENDRONATE SODIUM 77 77 24 30
ESCITALOPRAM OXALATE 76 76 26 46
ENALAPRIL MALEATE 76 71 26 25
FLUTICASONE PROPIONATE 70 70 28 41
WARFARIN SODIUM 63 63 29 11
FLOVENT HFA 62 60 30 242
METOPROLOL TARTRATE 60 60 31 10
ADVAIR DISKUS 59 59 32 36
TOPROL XL 58 58 33 227
PREDNISONE 56 54 34 54
AMOX TR-POTASSIUM CLAVULANATE 54 52 35 107
TRIAMTERENE-HCTZ 54 54 35 87
KLOR-CON 10 53 53 37 171
DONEPEZIL HCL 51 51 38 20
FINASTERIDE 51 51 38 97
METFORMIN HCL ER 50 45 40 67
PAROXETINE HCL 50 50 40 77
WELCHOL 50 50 40 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.